BERGER FRANKLIN M

CIK 000127388514 companiesBOTHELL, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001273885

Recent Transactions

50 trades

Disposition to Issuer
ESSA Pharma Inc.$EPIX
Common Shares
2025-10-09−784,404→ 0 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-06-20+29,600→ 29,600 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-06-20+29,600→ 506,497 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2025-06-20+41,200→ 41,200 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-06-20−29,600→ 0 total
Award
Kezar Life Sciences, Inc.$KZR
Stock Option (right to buy)
2025-06-18+5,000→ 5,000 total
Purchase
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-16$3.36/sh−10,000→ 476,897 total
Purchase
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-16$3.36/sh+10,000→ 476,897 total
Purchase
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-15$3.19/sh−15,000→ 466,897 total
Purchase
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-15$3.19/sh+15,000→ 466,897 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-12-10$2.85/sh−359,606→ 451,897 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2024-06-21+41,200→ 41,200 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2024-06-21+29,600→ 29,600 total
Award
Kezar Life Sciences, Inc.$KZR
Stock Option (right to buy)
2024-06-20+50,000→ 50,000 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2024-06-16−33,150→ 0 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-06-16+33,150→ 811,503 total
Award
ESSA Pharma Inc.$EPIX
Options
2024-03-25+50,000→ 50,000 total
Disposition from Tender
Rain Oncology Inc.
Common Stock, par value $0.001 per share
2024-01-26−1,005,207→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−20,000→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−24,000→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−35,000→ 0 total
Purchase
ESSA Pharma Inc.$EPIX
Common Shares
2023-11-21$5.73/sh+23,259→ 784,404 total
Purchase
ESSA Pharma Inc.$EPIX
Common Stock
2023-11-03$5.99/sh+16,471→ 760,875 total
Purchase
ESSA Pharma Inc.$EPIX
Common Stock
2023-11-02$5.35/sh+60,000→ 744,404 total
Award
Rain Oncology Inc.
Stock Option (Right to Buy)
2023-08-09+35,000→ 35,000 total
Disposition to Issuer
Kezar Life Sciences, Inc.$KZR
Stock Option (Right to Buy)
2023-07-24−26,000→ 0 total
Disposition to Issuer
Kezar Life Sciences, Inc.$KZR
Stock Option (Right to Buy)
2023-07-24−26,000→ 0 total
Award
Kezar Life Sciences, Inc.$KZR
Stock Option (Right to Buy)
2023-07-24+26,000→ 26,000 total
Award
Kezar Life Sciences, Inc.$KZR
Stock Option (Right to Buy)
2023-07-24+26,000→ 26,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2023-06-16+46,750→ 46,750 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2023-06-16+33,150→ 33,150 total
Award
Kezar Life Sciences, Inc.$KZR
Stock Option (right to buy)
2023-06-15+35,000→ 35,000 total
Award
Atreca, Inc.
Stock Option (right to buy)
2023-06-13+12,000→ 12,000 total
Sale
ESSA Pharma Inc.$EPIX
Common Shares
2022-12-21$2.41/sh−37,889→ 718,738 total
Sale
ESSA Pharma Inc.$EPIX
Common Shares
2022-12-21$2.42/sh−34,334→ 684,404 total
Sale
ESSA Pharma Inc.$EPIX
Common Shares
2022-12-20$2.53/sh−43,617→ 756,627 total
Sale
ESSA Pharma Inc.$EPIX
Common Shares
2022-12-16$2.67/sh−50,000→ 800,244 total
Sale
ESSA Pharma Inc.$EPIX
Common Shares
2022-12-15$2.86/sh−50,000→ 850,244 total
Sale
ESSA Pharma Inc.$EPIX
Common Shares
2022-12-15$2.90/sh−32,000→ 900,244 total
Sale
ESSA Pharma Inc.$EPIX
Common Shares
2022-12-14$3.00/sh−25,000→ 932,244 total
Purchase
Rain Oncology Inc.
Common Stock
2022-11-22$8.27/sh+77,000→ 1,005,207 total
Purchase
Rain Oncology Inc.
Common Stock
2022-11-21$7.80/sh+45,000→ 928,207 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2022-11-14$5.16/sh−16,166→ 778,353 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2022-11-11$5.15/sh−25,500→ 794,519 total
Purchase
Rain Oncology Inc.
Common Stock
2022-11-08$5.83/sh+42,881→ 883,207 total
Award
ESSA Pharma Inc.$EPIX
Stock Option (Right to Buy)
2022-06-29+22,500→ 22,500 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2022-06-17+61,264→ 61,264 total
Award
Kezar Life Sciences, Inc.$KZR
Stock Option (right to buy)
2022-06-16+26,000→ 26,000 total
Award
Atreca, Inc.
Stock Option (right to buy)
2022-06-08+12,000→ 12,000 total
Award
Rain Oncology Inc.
Stock Option (Right to Buy)
2022-06-01+20,000→ 20,000 total

Companies

Recent Filings

Address

21823 30TH DRIVE SE

BOTHELL, WA, 98021

View on SEC.gov